Showing results (11-20 of 268) with videos related to

Sort By:
Pageof 27
Neuroreport|January 20, 1997
MK-801 inhibits the cortical increase in IGF-1, IGFBP-2 and IGFBP-4 expression following traumaA C Nordqvist, S Holmin, M Nilsson, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|March 27, 2002
Depolarization induces insulin-like growth factor binding protein-2 expression in vivo via NMDA receptor stimulationS Holmin, T Mathiesen, I A Langmoen, et al.
Neuroscience Letters|November 13, 2001
Induction of astrocytic nestin expression by depolarization in ratsS Holmin, C von Gertten, A C Sandberg-Nordqvist, et al.
Journal of Neurosurgery|March 1, 1997
Delayed cytokine expression in rat brain following experimental contusionS Holmin, M Schalling, B Höjeberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Immunopathology of metastases in patients of colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factorJ Shetye, P Ragnhammar, M Liljefors, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A)J Shetye, J E Frödin, B Christensson, et al.
Hybridoma|August 1, 1988
Clinical effects of monoclonal antibodies (MAb 17-1A) in patients with metastatic colorectal carcinomasJ E Frödin, U Harmenberg, P Biberfeld, et al.
Acta Neurochirurgica|December 20, 2005
Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in ratsS Rudehill, S Muhallab, A Wennersten, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinomaH Mellstedt, J E Frödin, P Ragnhammar, et al.
Pageof 27